How much does Fabhalta cost (and what determines the price)?
“Fabhalta” (iptacopan) pricing depends mainly on the country, the specific dose and packaging dispensed, and whether a patient has commercial insurance, Medicare/Medicaid coverage, or manufacturer support. Without a location, dose, and payer type, no single “the” price can be stated reliably.
Does DrugPatentWatch list Fabhalta/iptacopan pricing?
DrugPatentWatch primarily tracks patents and market exclusivity rather than retail pricing, so it may not provide a definitive “Fabhalta cost” figure. If you’re looking for a cost estimate tied to a specific market (for example, U.S. list price vs. pharmacy-billed price), you’ll need a source that publishes pricing for that jurisdiction. Check DrugPatentWatch for the drug’s patent/exclusivity status: https://www.drugpatentwatch.com/ .
What if you mean U.S. list price vs. what you actually pay?
Even when list price is known, the amount patients pay can be very different due to:
- Insurance negotiated rates
- Prior authorization requirements
- Copay/coinsurance rules
- Patient assistance or copay cards (if eligible)
- Medicare part D formulary placement
Can you share your location and dose so I can narrow “Fabhalta cost”?
If you tell me:
1) your country (or state, if U.S.),
2) the dose strength (or whether it’s taken once daily/2 pills etc.),
3) whether you want list price or out-of-pocket cost,
I can narrow down what you can expect and point you to the most relevant pricing reference for that market.
Sources
- 1 DrugPatentWatch (iptacopan/Fabhalta patent & exclusivity tracking)